Announcements and Notices - [Other - Miscellaneous / Change in Registered Address or Office, Registered Place of Business in HK or Agent for Service of Process in HK]

3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.

(1) Cancellation Of Treasury Shares; And
 (2) Change Of Address Of Principal Place Of
Business In Hong Kong

Announcements and Notices - [Other - Business Update]

Voluntary Announcement
Cooperation Between Shenyang Sunshine
And Sunshine Lake Pharma In Respect Of
Clifutinib Besylate

Voluntary Announcement - Mandi Ranked The First Place On Multiple Platforms In "Double 11" Of 2024

Announcements and Notices - [Other - Miscellaneous]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3SBio Inc (1530 HK)

(1) Cancellation Of Treasury Shares; And (2) Change Of Address Of Principal Place Of Business In Hong Kong

Voluntary Announcement Cooperation Between Shenyang Sunshine And Sunshine Lake Pharma In Respect Of Clifutinib Besylate

Voluntary Announcement - Mandi Ranked The First Place On Multiple Platforms In "Double 11" Of 2024

Voluntary Announcement - Increase In Shareholding By Chief Financial Officer

Voluntary Announcement Shenyang Sunshine Has Entered Into A Cooperation Agreement With Haihe Biopharma In Respect Of Paclitaxel Oral Solution

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)